首页> 外国专利> method for the preparation of enantiomerically pure mirtazapine; and, method for selecting an appropriate acid or solvent / acid combination for a stereospecifically ring-closing reaction of enantiomerically pure compound

method for the preparation of enantiomerically pure mirtazapine; and, method for selecting an appropriate acid or solvent / acid combination for a stereospecifically ring-closing reaction of enantiomerically pure compound

机译:对映体纯的米氮平的制备方法;以及为对映体纯的化合物的立体定向闭环反应选择合适的酸或溶剂/酸组合的方法

摘要

"METHOD FOR PREPARING ENANTIOMERICALLY PURE MIRTAZAPINE, AND METHOD FOR SELECTING AN ACID / SOLVENT APPROPRIATE FOR A STEREO SPECIFICLY COMPOUND COMPOUND RING CLOSING REACTION. The invention provides a method for the preparation of enantiomerically pure mirtazapine, comprising a ring closing step of a compound of formula (II) wherein X is a leaving group, the step of which comprises treatment with an acid, whereby mirtazapine Enantiomeric excess is formed by ring-closing of the enantiomeric excess compound of formula (II) by treatment with an appropriate acid in the absence of a solvent or an appropriate combination of an acid and an organic solvent.
机译:“用于制备对映体纯的米氮他滨的方法,以及选择适合于立体特定复合化合物的闭环反应的酸/溶剂的方法。本发明提供了一种用于制备对映体纯的mirtazapine的方法,该方法包括式(II)化合物的闭环步骤(II)其中X是离去基团,其步骤包括用酸处理,由此通过在不存在的条件下用适当的酸处理闭环式(II)的对映体过量化合物来形成米氮平对映体过量。溶剂或酸和有机溶剂的适当组合。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号